Grid Oasis
S&P 500NASDAQ 100Dow JonesRussell 2000All StocksSectors & Industries

OABI

+ Watchlist+ Portfolio

OmniAb, Inc.

Regulated industrySells to businessesTags from an AI model reading the company description.
GridBrain

GridBrain — Sign in

GridSentinel

GridSentinel — Sign in

GridAegis

GridAegis — Sign in

Key Metrics

Previous Close
$5.05
52-Week Range
$1.35 – $5.45
Market Cap
$740.97M
P/E (TTM)
—
EPS (TTM)
-0.34
Dividend Yield
0.00%
Advanced Metrics
Price/Book
2.97
PEG Ratio
—
Return on Equity
-16.51%
Return on Assets
-7.78%
Gross Margin
97.66%
Operating Margin
-92.91%
Profit Margin
-108.11%
Current Ratio
4.21
Debt/Equity
0.07
Total Debt
$18.14M
Free Cash Flow
$10.19M
Revenue Growth
78.30%
Earnings Growth
—
Enterprise Value
$694.90M

Market Snapshot

About

OmniAb Inc. provides antibody discovery platforms for biopharmaceutical companies. The company offers transgenic animal and in vitro technologies that enable partners to discover and develop human therapeutic antibodies and other biologics.